Bayer says Parkinson’s stem cell therapy improves symptoms in initial trial

Bayer https://www.reuters.com/markets/companies/BAYGn.DE” target=”_blank” rel=”noopener”>(BAYGn.DE) said an experimental stem cell therapy developed by its U.S. subsidiary BlueRock had shown signs of easing Parkinson’s disease symptoms in an early 12-patient tr…
Read More

About The Author

Jonathan Jeriah

See author's posts